M 30
Pill imprint M 30 has been identified as Clorazepate dipotassium 3.75 mg.
Clorazepate is used in the treatment of alcohol withdrawal; anxiety; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy.
Clorazepate 3.75 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Clorazepate dipotassium Images
- Imprint:
-
M 30
- Strength:
- 3.75 mg
- Color:
- Blue
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
FD&C Blue No. 2
magnesium oxide
magnesium stearate
microcrystalline cellulose
potassium carbonate
sodium chloride
sodium lauryl sulfate
- Drug Class:
- Benzodiazepines
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0030
Advertisement
More Clorazepate Dipotassium resources
- Clorazepate (Wolters Kluwer)
- Clorazepate Sustained-Release Tablets (Wolters Kluwer)
- clorazepate (Cerner Multum)
- Gen-Xene (Micromedex) - Includes Dosage Information
- clorazepate (Micromedex) - Includes Dosage Information
- Clorazepate Dipotassium (AHFS DI)
- Clorazepate (FDA)
- Clorazepate Dipotassium (Wolters Kluwer)
Search Again
